- Past, present, and future of Intestinal Research
-
Cheon JH
- KMID: 2539003
- Intest Res.
- 2023 Jan;21(1):1-2.
- doi: 10.5217/ir.2023.00010
-
- CITED
-
- Close
- SHARE
-
- Close
- The role and prospect of tofacitinib in patients with ulcerative colitis
-
Lee J
- KMID: 2539015
- Intest Res.
- 2023 Jan;21(1):168-169.
- doi: 10.5217/ir.2022.00098
-
- CITED
-
- Close
- SHARE
-
- Close
- The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
-
Cheon JH, Paridaens K, Awadhi SA, Begun J, Fullarton JR, Louis E, Magro F, Marquez JR, Moschen AR, Narula N, Rydzewska G, Dignass AU, Travis SP
- KMID: 2539014
- Intest Res.
- 2023 Jan;21(1):161-167.
- doi: 10.5217/ir.2022.00006
-
- CITED
-
- Close
- SHARE
-
- Close
- Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
-
Koh SJ, Hong SN, Park SK, Ye BD, Kim KO, Shin JE, Yoon YS, Lee HS, Jung SH, Choi M, Na SY, Choi CH, Kim JS, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539006
- Intest Res.
- 2023 Jan;21(1):43-60.
- doi: 10.5217/ir.2022.00029
Crohn’s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
-
Lee HH, Kim JS, Goong HJ, Lee SH, Oh EH, Park J, Kim MC, Nam K, Yang YJ, Kim TJ, Nam SJ, Moon HS, Kim JH, Kim DH, Kim SE, Jeon SR, Myung SJ, The Small Intestine Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
- KMID: 2539004
- Intest Res.
- 2023 Jan;21(1):3-19.
- doi: 10.5217/ir.2022.00108
The introduction of device-assisted enteroscopy (DAE) in the beginning of 21st century has revolutionized the diagnosis and treatment of diseases of the small intestine. In contrast to capsule endoscopy, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis
-
Sakurai K, Katsurada T, Nishida M, Omotehara S, Fukushima S, Otagiri S, Nagashima K, Onishi R, Takagi R, Komatsu Y, Sakamoto N
- KMID: 2539011
- Intest Res.
- 2023 Jan;21(1):126-136.
- doi: 10.5217/ir.2021.00166
Background/Aims: The usefulness of ultrasonography (US) in diseases of the gastrointestinal tract has been reported recently. This prospective study aimed to determine the features of US findings in immune-mediated colitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
-
Matsuoka K, Togo K, Yoshii N, Hoshi M, Arai S
- KMID: 2539008
- Intest Res.
- 2023 Jan;21(1):88-99.
- doi: 10.5217/ir.2021.00154
Background/Aims: Patients with ulcerative colitis (UC) are at an increased risk of certain infections and malignancies compared with the general population. Incidence rates (IRs) of hospitalized infections, herpes zoster (HZ),... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
-
Oh K, Hong HS, Ham NS, Lee J, Park SH, Yang SK, Yoon H, Kim YS, Choi CH, Ye BD, on behalf of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539012
- Intest Res.
- 2023 Jan;21(1):137-147.
- doi: 10.5217/ir.2021.00173
Background/Aims: We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD). Methods: CD patients who started UST were prospectively enrolled from 4... -
- CITED
-
- Close
- SHARE
-
- Close
- Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
-
Shin SY, Kim Y, Kim WS, Moon JM, Lee KM, Jung SA, Park H, Huh EY, Kim BC, Lee SC, Choi CH, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539013
- Intest Res.
- 2023 Jan;21(1):148-160.
- doi: 10.5217/ir.2021.00168
Background/Aims: The fecal microbiota of Korean patients with inflammatory bowel disease (IBD) was investigated with respect to disease phenotypes and taxonomic biomarkers for diagnosis and prognosis of IBD. Methods: Fecal samples... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
-
Tsai KY, You JF, Tsai TY, Chern YJ, Hsu YJ, Huang SH, Tsai WS
- KMID: 2539009
- Intest Res.
- 2023 Jan;21(1):100-109.
- doi: 10.5217/ir.2021.00110
Background/Aims: Exacerbating factors of ulcerative colitis (UC) are multiple and complex with individual influence. We aimed to evaluate the efficacy of disease control by searching and restricting inflammation trigger factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
-
Na SY, Choi CH, Song EM, Bang KB, Park SH, Kim ES, Park JJ, Keum B, Lee CK, Lee BI, Ryoo SB, Koh SJ, Choi M, Kim JS, On behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539007
- Intest Res.
- 2023 Jan;21(1):61-87.
- doi: 10.5217/ir.2022.00007
Ulcerative colitis (UC), a relapsing-remitting chronic inflammatory bowel disease (IBD), has a variable natural course but potentially severe disease course. Since the development of anti-tumor necrosis factor (TNF) agents has... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
-
Hibi T, Motoya S, Hisamatsu T, Hirai F, Watanabe K, Matsuoka K, Saruta M, Kobayashi T, Feagan BG, Tasset C, Besuyen R, Yun C, Crans G, Zhang J, Kondo A, Watanabe M
- KMID: 2539010
- Intest Res.
- 2023 Jan;21(1):110-125.
- doi: 10.5217/ir.2021.00143
Background/Aims: The safety and efficacy of filgotinib, a once-daily oral Janus kinase 1 preferential inhibitor, were evaluated in Japanese patients with ulcerative colitis (UC) in the phase 2b/3 SELECTION trial. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition
-
Kim SY, Kwak MS, Yoon SM, Jung Y, Kim JW, Boo SJ, Oh EH, Jeon SR, Nam SJ, Park SY, Park SK, Chun J, Baek DH, Choi MY, Park S, Byeon JS, Kim HK, Cho JY, Lee MS, Lee OY, Korean Society of Gastrointestinal Endoscopy, Korean Society of Gastroenterology, Korean Association for the Study of Intestinal Diseases
- KMID: 2539005
- Intest Res.
- 2023 Jan;21(1):20-42.
- doi: 10.5217/ir.2022.00096
Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance... -
- CITED
-
- Close
- SHARE
-
- Close
